Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 77 entries
View as:

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

Phase: N/A Priority: Normal
NCT ID: NCT06555783 Org: User:
Start: 07/26/24 End: 09/30/25 Due: 09/30/26

A Study of ALKS 5461 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02068105 Org: User:
Start: 01/31/14 End: 03/31/14 Due: 03/31/15

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Phase: N/A Priority: Normal
NCT ID: NCT01218984 Org: User:
Start: 03/31/02 End: 05/31/03 Due: 05/31/04

A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02504463 Org: User:
Start: 06/30/15 End: 09/30/15 Due: 09/30/16

A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

Phase: N/A Priority: Normal
NCT ID: NCT02634346 Org: User:
Start: 12/31/15 End: 06/07/17 Due: 06/07/18

ALK29-002: A Study of Baclofen Formulations in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00802035 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT03188185 Org: User:
Start: 06/12/17 End: 03/05/20 Due: 03/05/21

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

Phase: N/A Priority: Normal
NCT ID: NCT03577262 Org: User:
Start: 07/23/18 End: 08/02/19 Due: 08/02/20

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04987658 Org: User:
Start: 07/22/21 End: 08/11/23 Due: 08/11/24

A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

Phase: N/A Priority: Normal
NCT ID: NCT02694328 Org: User:
Start: 03/02/16 End: 11/07/18 Due: 11/07/19

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Phase: N/A Priority: Normal
NCT ID: NCT06767683 Org: User:
Start: 01/27/25 End: 11/30/27 Due: 11/30/28

A Long-Term Safety Study of ALKS 5461

Phase: N/A Priority: Normal
NCT ID: NCT02141399 Org: User:
Start: 05/31/14 End: 11/20/17 Due: 11/20/18

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Phase: N/A Priority: Normal
NCT ID: NCT01100151 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

Phase: N/A Priority: Normal
NCT ID: NCT00501631 Org: User:
Start: 07/31/07 End: 03/31/11 Due: 03/31/12

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Phase: N/A Priority: Normal
NCT ID: NCT01626456 Org: User:
Start: 06/30/12 End: 04/30/15 Due: 04/30/16

A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02669758 Org: User:
Start: 01/20/16 End: 06/29/18 Due: 06/29/19

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05303064 Org: User:
Start: 06/30/22 End: 09/30/26 Due: 09/30/27

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04987229 Org: User:
Start: 10/22/21 End: 09/30/27 Due: 09/30/28

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01500200 Org: User:
Start: 12/31/11 End: 03/31/13 Due: 03/31/14

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

Phase: N/A Priority: Normal
NCT ID: NCT01218958 Org: User:
Start: 02/28/02 End: 09/30/03 Due: 09/30/04

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT02085135 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Phase: N/A Priority: Normal
NCT ID: NCT00678418 Org: User:
Start: 06/30/08 End: 11/30/10 Due: 11/30/11

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

Phase: N/A Priority: Normal
NCT ID: NCT01422837 Org: User:
Start: 08/31/11 End: 10/31/13 Due: 10/31/14

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Phase: N/A Priority: Normal
NCT ID: NCT02537574 Org: User:
Start: 08/31/15 End: 01/09/17 Due: 01/09/18

ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence

Phase: N/A Priority: Normal
NCT ID: NCT00981617 Org: User:
Start: 10/31/09 End: 08/31/10 Due: 08/31/11